Penserra Capital Management LLC Buys 5,713 Shares of Lam Research Corporation $LRCX

Penserra Capital Management LLC raised its stake in shares of Lam Research Corporation (NASDAQ:LRCXFree Report) by 2.3% during the second quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 250,963 shares of the semiconductor company’s stock after purchasing an additional 5,713 shares during the period. Penserra Capital Management LLC’s holdings in Lam Research were worth $24,427,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Several other institutional investors have also modified their holdings of the stock. Wedbush Securities Inc. increased its position in shares of Lam Research by 19.5% during the 2nd quarter. Wedbush Securities Inc. now owns 20,968 shares of the semiconductor company’s stock valued at $2,041,000 after purchasing an additional 3,425 shares during the last quarter. Vestmark Advisory Solutions Inc. purchased a new position in Lam Research during the second quarter worth $483,000. Walkner Condon Financial Advisors LLC bought a new position in Lam Research during the second quarter valued at $222,000. Smart Money Group LLC bought a new position in Lam Research during the second quarter valued at $280,000. Finally, Savant Capital LLC raised its stake in shares of Lam Research by 47.0% in the second quarter. Savant Capital LLC now owns 42,886 shares of the semiconductor company’s stock valued at $4,174,000 after acquiring an additional 13,712 shares during the period. 84.61% of the stock is owned by institutional investors.

Insider Transactions at Lam Research

In other news, SVP Vahid Vahedi sold 52,190 shares of the stock in a transaction that occurred on Monday, October 13th. The shares were sold at an average price of $138.90, for a total transaction of $7,249,191.00. Following the transaction, the senior vice president directly owned 251,047 shares in the company, valued at approximately $34,870,428.30. This trade represents a 17.21% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Also, Director Bethany Mayer sold 1,298 shares of Lam Research stock in a transaction that occurred on Monday, November 3rd. The shares were sold at an average price of $159.99, for a total transaction of $207,667.02. Following the transaction, the director directly owned 1,652 shares in the company, valued at approximately $264,303.48. The trade was a 44.00% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. In the last quarter, insiders sold 62,498 shares of company stock valued at $8,875,663. Company insiders own 0.31% of the company’s stock.

Analyst Upgrades and Downgrades

A number of equities analysts recently commented on LRCX shares. Rothschild & Co Redburn lifted their price target on shares of Lam Research from $140.00 to $150.00 and gave the stock a “buy” rating in a research note on Tuesday, October 14th. Hsbc Global Res upgraded Lam Research to a “hold” rating in a research report on Tuesday, September 30th. Wall Street Zen cut Lam Research from a “buy” rating to a “hold” rating in a research note on Saturday. Argus raised their price target on Lam Research from $105.00 to $120.00 and gave the stock a “buy” rating in a research note on Friday, August 1st. Finally, JPMorgan Chase & Co. upped their price objective on Lam Research from $113.00 to $165.00 and gave the company an “overweight” rating in a research report on Thursday, October 23rd. One analyst has rated the stock with a Strong Buy rating, twenty-six have issued a Buy rating and nine have assigned a Hold rating to the stock. According to data from MarketBeat.com, Lam Research currently has an average rating of “Moderate Buy” and an average target price of $148.54.

Get Our Latest Stock Report on Lam Research

Lam Research Trading Down 1.8%

LRCX opened at $159.35 on Friday. The company has a quick ratio of 1.60, a current ratio of 2.21 and a debt-to-equity ratio of 0.37. The stock’s fifty day moving average is $134.94 and its two-hundred day moving average is $106.31. The company has a market capitalization of $200.15 billion, a P/E ratio of 35.10, a PEG ratio of 1.68 and a beta of 1.87. Lam Research Corporation has a 52 week low of $56.32 and a 52 week high of $166.92.

Lam Research (NASDAQ:LRCXGet Free Report) last posted its quarterly earnings results on Wednesday, October 22nd. The semiconductor company reported $1.26 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.22 by $0.04. The business had revenue of $5.32 billion for the quarter, compared to the consensus estimate of $5.23 billion. Lam Research had a return on equity of 60.60% and a net margin of 29.66%.The business’s revenue was up 27.7% compared to the same quarter last year. During the same quarter in the prior year, the company earned $0.86 EPS. Lam Research has set its Q2 2026 guidance at 1.050-1.250 EPS. Analysts forecast that Lam Research Corporation will post 3.71 earnings per share for the current year.

Lam Research Announces Dividend

The firm also recently declared a quarterly dividend, which will be paid on Wednesday, January 7th. Stockholders of record on Wednesday, December 3rd will be issued a $0.26 dividend. The ex-dividend date is Wednesday, December 3rd. This represents a $1.04 annualized dividend and a dividend yield of 0.7%. Lam Research’s payout ratio is currently 22.91%.

Lam Research Profile

(Free Report)

Lam Research Corporation designs, manufactures, markets, refurbishes, and services semiconductor processing equipment used in the fabrication of integrated circuits. The company offers ALTUS systems to deposit conformal films for tungsten metallization applications; SABRE electrochemical deposition products for copper interconnect transition that offers copper damascene manufacturing; SOLA ultraviolet thermal processing products for film treatments; and VECTOR plasma-enhanced CVD ALD products.

Read More

Institutional Ownership by Quarter for Lam Research (NASDAQ:LRCX)

Receive News & Ratings for Lam Research Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Lam Research and related companies with MarketBeat.com's FREE daily email newsletter.